drugset / Trial / NCT02111499
Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
RandomizedParallel-groupDouble-blindTreatment
Summary
Clinical investigation of anti-psoriatic efficacy and atrophy
Timeline
- Start
- 2014-03
- Primary completion
- 2014-05
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAS41004 IMP2 | Unknown | — | Topical |
| Subject | LAS41004 IMP3 | Unknown | — | Topical |
| Subject | LAS41004 IMP4 | Unknown | — | Topical |
| Subject | LAS41004 IMP5 | Unknown | — | Topical |
| Subject | LAS41004 IMP6 | Unknown | — | Topical |
| Subject | LAS41004-IMP1 | Unknown | — | Topical |